Publicacións en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Epidemiología Y Salud Pública (54)

2024

  1. Assessment of effectiveness and impact of universal prophylaxis with nirsevimab for prevention of hospitalizations due to respiratory syncytial virus in infants. The NIRSE-GAL study protocol

    Human Vaccines and Immunotherapeutics, Vol. 20, Núm. 1

  2. Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

    The Lancet Infectious Diseases, Vol. 24, Núm. 8, pp. 817-828

  3. Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain

    Influenza and other Respiratory Viruses, Vol. 18, Núm. 5

  4. Evolution of sedentarism prevalence in Spanish population between 1987 and 2020

    Medicina Clinica, Vol. 162, Núm. 6, pp. 273-279

  5. Evolution of smoking prevalence in Spain and its 17 autonomous regions (1987-2020)

    Medicina Clinica, Vol. 162, Núm. 9, pp. 417-424

  6. Prevalence of obesity in Spain and its autonomous communities, 1987-2020

    Revista Espanola de Cardiologia, Vol. 77, Núm. 10, pp. 809-818

  7. Self-perceived body weight and weight status: analysis of concordance by age group and sex

    Public Health, Vol. 229, pp. 160-166

  8. Severity of respiratory syncytial virus compared with SARS-CoV-2 and influenza among hospitalised adults ≥65 years

    Journal of Infection, Vol. 89, Núm. 5

  9. Short- and mid-term morbidity and primary-care burden due to infant respiratory syncytial virus infection: A Spanish 6-year population-based longitudinal study

    Pediatric Allergy and Immunology, Vol. 35, Núm. 5

  10. Time Dependence Between Tobacco Consumption and Lung Cancer Mortality in Spain

    Archivos de Bronconeumologia

2023

  1. Attributable mortality to tobacco consumption in Brazil, 1996-2019

    Gaceta Sanitaria, Vol. 37

  2. Effectiveness of a Meningococcal Group B Vaccine (4CMenB) in Children

    New England Journal of Medicine, Vol. 388, Núm. 5, pp. 427-438

  3. Estimations of smoking-attributable mortality in Spain at a regional level: comparison of two methods

    Annals of Epidemiology, Vol. 82, pp. 77-83.e3

  4. Lifting COVID-19 mitigation measures in Spain (May–June 2020)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 41, Núm. 1, pp. 11-17

  5. Mortality Attributable to Environmental Tobacco Smoke Exposure in Spain in 2020

    Archivos de Bronconeumologia, Vol. 59, Núm. 5, pp. 305-310

  6. Physical activity during pregnancy and postpartum: prevalence and healthcare professionals recommendations

    Atencion Primaria, Vol. 55, Núm. 5

  7. Sedentary behavior and physical inactivity from a comprehensive perspective

    Gaceta Sanitaria, Vol. 37

  8. Short version of the Minnesota Leisure Time Physical Activity Questionnaire for general population: MLTPAQ 9 + 2

    Gaceta Sanitaria, Vol. 37

  9. Small-area models to assess the geographical distribution of tobacco consumption by sex and age in Spain

    Tobacco Induced Diseases, Vol. 21, Núm. May

  10. Smoking-attributable mortality in Portugal and its regions in 2019

    Pulmonology